Stop use of 10 fluids, including ringer’s lactate infusion, state asks govt hospitals

Kolkata:  The state Health department on Saturday issued an order asking all government hospitals to stop using 10 fluids, including ringer’s lactate infusion, for the safety of patients in the wake of the death of a 21-year-old woman who gave birth to a child at Midnapore Medical College and died at the hospital on Friday after allegedly being administered “expired” saline.

On instructions of CM Mamata Banerjee, who also heads the Health department, Chief Secretary Manoj Pant has sought a detailed report on the incident from the Principal Secretary, Health, by Sunday night.

The detailed list of the fluids have been circulated among all health establishments in the state.Meanwhile, the 13-member team that has been constituted by the Health department to probe the incident visited Midnapore Medical College on Saturday and sought individual written opinions from the doctors on the incident.

The team also spoke with three of the four patients, who were administered the same saline at the hospital and subsequently fell ill. Members could not speak to one of them, Nasreen Khatun, as her condition is extremely critical and has been put on ventilator support since Friday.

“The treatment that is presently being offered to these four patients is going in the right direction,” said a member of the committee.

The 13-member committee later held a meeting at Midnapore circuit house with the District Magistrate and Chief Medical Officer (CMO) in the presence of other concerned officials. According to sources in the Health department, the committee will also probe whether the incident happened due to the negligence of any doctor/doctors in the hospital.

The ringer’s lactate saline supplied by a Siliguri-based pharma company has come under the scanner of the Health department following the incident. The state Drug Control on December 10 had blacklisted the company. “It will be examined whether the infusion administered was procured after the blacklisting or it was in stock earlier. If it was in stock, it should have been exhausted,” a Health department official said.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch